Quanterix Corp at Barclays Global Healthcare Conference Transcript
All right. Good morning, everybody. Good morning. My name is Luke Sergott. I cover life science tools and diagnostics. I have with me Kevin Hrusovsky and Masoud Toloue of Quanterix. Kind of get your names right.
That was pretty good, Luke.
It was pretty close. There's a lot of confidence there leading off. So I guess you guys want to go over a couple of slides here if you want to go over and then we'll dig into some Q&A.
Yes. So maybe just to start off, if much of -- just from the standpoint of Quanterix, it's really great to be here first, Luke. And I do think that this is a very pivotal moment for our company. We're at a very important, inflection point given the Lilly deal that we were
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
